Biotech companies, whether they are establishing their legacy or just entering the field, are on the brink of major achievements in scientific innovation and mission-driven work.
Yet, amidst rapid growth and change, they often neglect to actively cultivate this mission through culture, communication, and engaging experiences like events and learning opportunities. Many businesses choose to address these “corporate” priorities at a later stage, a choice that can increase the risk of stumbling during the critical transition from start-up to established player.
Without a clearly defined and consistently applied mission, companies may find themselves years down the line with a lack of direction and cohesion, driven only by scientific ambitions and inconsistent behaviors.
So, how do you get this right? Hear from Allen Putman, Senior Communications and Engagement Consultant, Forty1 North America and Dean McAlister, EVP, Inizio, as they discuss how to build and balance a high culture to maximize your organizational potential here.
Jump to a slide with the slide dots.
This year’s MAPS Americas Congress brought together the brightest in Medical Affairs - the message was clear: innovation is no longer a differentiator
Read moreExplore 5 key AI insights from Reuters Pharma USA 2025—learn how life sciences leaders are using AI to drive humanized engagement, action...
Read moreDiscover how AI-powered speech analytics is revolutionizing customer experience, improving compliance, and enabling smarter decision-making at scale.
Read more